CD8A and Huntington disease: HCMV+ HD with anti-HLA-A2pp65 CD8 T (n = 37) include HD with anti-HLA-A2pp65 CD8 T only (64.9%) or with a dual response composed of anti-HLA-A2pp65 and anti HLA-EUL40 CD8 T cells (35.1%).